Squarepoint Ops LLC Theravance Biopharma, Inc. Transaction History

Squarepoint Ops LLC

$96.1 Billion
Q3 2025

A detailed history of Squarepoint Ops LLC transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 46,750 shares of TBPH stock, worth $812,982. This represents 0.0% of its overall portfolio holdings.

Number of Shares

46,750

Previous 13,322 250.92%

Holding current value

$812,982

Previous $146,000 367.12%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$10.9 - $14.6 $364,365 - $488,048	33,428 Added 250.92%	46,750 $682,000
Q2 2025 Aug 27, 2025	SELL	$8.32 - $11.25 $86,902 - $117,506	-10,445 Reduced 43.95%	13,322 $146,000
Q2 2025 Aug 14, 2025	SELL	$8.32 - $11.25 $86,902 - $117,506	-10,445 Reduced 43.95%	13,322 $146,000
Q1 2025 Aug 27, 2025	BUY	$8.44 - $10.47 $88,155 - $109,359	10,445 Added 78.4%	23,767 $212,000
Q1 2025 May 15, 2025	SELL	$8.44 - $10.47 $197,504 - $245,008	-23,401 Reduced 49.61%	23,767 $212,000

Q4 2024 Feb 14, 2025	SELL	$7.93 - $10.08 $410,639 - $521,972	-51,783 Reduced 52.33%	47,168 $443,000
Q3 2024 Nov 14, 2024	SELL	$7.66 - $10.25 $132,556 - $177,376	-17,305 Reduced 14.89%	98,951 $797,000
Q2 2024 Aug 14, 2024	BUY	$8.29 - $9.92 $963,762 - $1.15 Million	116,256 New	116,256 $985,000
Q4 2023 Feb 14, 2024	BUY	$8.58 - $11.4 $28,725 - $38,167	3,348 Added 6.87%	52,054 $585,000
Q2 2023 Aug 14, 2023	SELL	$10.16 - $11.92 $10,871 - $12,754	-1,070 Reduced 2.15%	48,706 $504,000
Q1 2023 May 15, 2023	SELL	$9.87 - $11.44 $182,624 - $211,674	-18,503 Reduced 27.1%	49,776 $540,000
Q4 2022 Feb 14, 2023	BUY	$9.65 - $11.34 $130,786 - $153,691	13,553 Added 24.77%	68,279 $766,000
Q3 2022 Nov 14, 2022	BUY	$8.39 - $10.22 $299,866 - $365,273	35,741 Added 188.26%	54,726 $555,000
Q2 2022 Aug 15, 2022	BUY	$8.41 - $10.34 $159,663 - $196,304	18,985 New	18,985 $172,000
Q1 2022 May 16, 2022	SELL	$8.33 - $12.96 $133,038 - $206,984	-15,971 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$7.42 - $11.05 $142,872 - $212,767	-19,255 Reduced 54.66%	15,971 $176,000
Q3 2021 Nov 15, 2021	BUY	$6.77 - $14.41 $238,480 - $507,606	35,226 New	35,226 $261,000
Q4 2020 Feb 16, 2021	SELL	$14.89 - $20.16 $743,293 - $1.01 Million	-49,919 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$14.79 - $22.49 $563,040 - $856,171	38,069 Added 321.26%	49,919 $738,000
Q2 2020 Aug 14, 2020	BUY	$20.64 - $30.69 $244,584 - $363,676	11,850 New	11,850 $249,000
Q4 2019 Feb 14, 2020	SELL	$16.12 - $25.89 $799,906 - $1.28 Million	-49,622 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$16.51 - $23.78 $106,307 - $153,119	-6,439 Reduced 11.49%	49,622 $967,000
Q2 2019 Aug 14, 2019	BUY	$15.6 - $25.15 $603,033 - $972,198	38,656 Added 222.1%	56,061 $915,000
Q1 2019 May 15, 2019	BUY	$22.57 - $28.15 $392,830 - $489,950	17,405 New	17,405 $395,000

Others Institutions Holding TBPH

# of Institutions

170

Shares Held

50.5M

Call Options Held

36.5K

Put Options Held

147K

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $1.16B
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Theravance Biopharma, Inc. Transaction History